{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:30:38Z","timestamp":1793035838222,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.maturitas.2014.05.001","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T04:31:31Z","timestamp":1400041891000},"page":"245-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Gout: Joints and beyond, epidemiology, clinical features, treatment and co-morbidities"],"prefix":"10.1016","volume":"78","author":[{"given":"Philip C.","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1011-7996","authenticated-orcid":false,"given":"Simon","family":"Horsburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2014.05.001_bib0005","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/rheumatology\/ker361","article-title":"National prevalence of gout derived from administrative health data in Aotearoa New Zealand","volume":"51","author":"Winnard","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0010","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2014-205304","article-title":"Hyperuricaemia and gout: time for a new staging system?","author":"Dalbeth","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0015","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1093\/rheumatology\/kem246","article-title":"Tophaceous joint disease strongly predicts hand function in patients with gout","volume":"46","author":"Dalbeth","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1524-4733.2007.00173.x","article-title":"The impact of gout on work absence and productivity","volume":"10","author":"Kleinman","year":"2007","journal-title":"Value Health"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3111\/13696998.2010.540874","article-title":"Work productivity loss due to flares in patients with chronic gout refractory to conventional therapy","volume":"14","author":"Edwards","year":"2011","journal-title":"J Med Econ"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0030","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1445-5994.2012.02794.x","article-title":"Systematic review of the prevalence of gout and hyperuricemia in Australia","volume":"42","author":"Robinson","year":"2012","journal-title":"Intern Med J"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0035","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1592\/phco.28.4.437","article-title":"Comparison of drug adherence rates among patients with seven different medical conditions","volume":"28","author":"Briesacher","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0040","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1136\/annrheumdis-2012-201687","article-title":"Gout: why is this curable disease so seldom cured","volume":"71","author":"Doherty","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0045","article-title":"Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study","author":"Kuo","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11926-011-0228-0","article-title":"The patient's experience of gout: new insights to optimize management","volume":"14","author":"Dalbeth","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0055","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ncomms1756","article-title":"Decreased extra-renal urate excretion is a common cause of hyperuricemia","volume":"3","author":"Ichida","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0060","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","article-title":"Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study","volume":"82","author":"Campion","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0065","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/art.27338","article-title":"Epidemiology of gout in women: fifty-two-year followup of a prospective cohort","volume":"62","author":"Bhole","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0070","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US General Population","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0075","article-title":"The global burden of gout: estimates from the Global Burden of Disease 2010 study","author":"Smith","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.rdc.2014.01.001","article-title":"Epidemiology of gout","volume":"40","author":"Roddy","year":"2014","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0085","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.semnephrol.2011.08.005","article-title":"Population heterogeneity in the genetic control of serum urate","volume":"31","author":"Merriman","year":"2011","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0090","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/ard.51.3.375","article-title":"Genetic control of the renal clearance of urate: a study of twins","volume":"51","author":"Emmerson","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0095","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.amjmed.2011.11.010","article-title":"Nature versus nurture in gout: a twin study","volume":"125","author":"Krishnan","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jbspin.2010.02.027","article-title":"The genetic basis of hyperuricaemia and gout","volume":"78","author":"Merriman","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0105","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrrheum.2012.144","article-title":"The genetics of hyperuricaemia and gout","volume":"8","author":"Reginato","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.rdc.2014.01.009","article-title":"The genetic basis of gout","volume":"40","author":"Merriman","year":"2014","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/ng.2500","article-title":"Genome-wide association analyses identify 18 new loci associated with serum urate concentrations","volume":"45","author":"Kottgen","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0120","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/bmj.39449.819271.BE","article-title":"Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study","volume":"336","author":"Choi","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0125","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(04)16000-5","article-title":"Alcohol intake and risk of incident gout in men: a prospective study","volume":"363","author":"Choi","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0130","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa035700","article-title":"Purine-rich foods, dairy and protein intake, and the risk of gout in men","volume":"350","author":"Choi","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0135","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MOL.0b013e3283613bca","article-title":"Adverse metabolic effects of dietary fructose: results from the recent epidemiological, clinical, and mechanistic studies","volume":"24","author":"Stanhope","year":"2013","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0140","first-page":"1","article-title":"Fructose: metabolism and short-term effects on carbohydrate and purine metabolic pathways","volume":"21","author":"Van den Berghe","year":"1986","journal-title":"Progr Biochem Pharmacol"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0145","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/art.22712","article-title":"Coffee consumption and risk of incident gout in men: a prospective study","volume":"56","author":"Choi","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0150","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1002\/art.34677","article-title":"Cherry consumption and decreased risk of recurrent gout attacks","volume":"64","author":"Zhang","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0155","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/annrheumdis-2011-200156","article-title":"Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomised controlled trial","volume":"71","author":"Dalbeth","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0160","first-page":"U2270","article-title":"Alcohol excess may be overemphasised in gout treated in secondary care","volume":"119","author":"Dalbeth","year":"2006","journal-title":"N Z Med J"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.293.1.43","article-title":"Comparison of the atkins, ornish, weight watchers, and zone diets for weight loss and heart disease risk reduction: a randomized trial","volume":"293","author":"Dansinger","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0170","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.appet.2005.01.008","article-title":"Self-set dieting rules: adherence and prediction of weight loss success","volume":"44","author":"Knauper","year":"2005","journal-title":"Appetite"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0175","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/art.33315","article-title":"Diuretic use, increased serum urate levels, and risk of incident gout in a population-based study of adults with hypertension: the Atherosclerosis Risk in Communities cohort study","volume":"64","author":"McAdams DeMarco","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0180","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/annrheumdis-2011-201186","article-title":"A urate gene-by-diuretic interaction and gout risk in participants with hypertension: results from the ARIC study","volume":"72","author":"McAdams-DeMarco","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0185","doi-asserted-by":"crossref","first-page":"d8190","DOI":"10.1136\/bmj.d8190","article-title":"Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case\u2013control study","volume":"344","author":"Choi","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0190","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/annrheumdis-2012-202589","article-title":"Low-dose aspirin use and recurrent gout attacks","volume":"73","author":"Zhang","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0195","first-page":"1853","article-title":"Vitamin C intake and serum uric acid concentration in men","volume":"35","author":"Gao","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0200","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/archinternmed.2008.606","article-title":"Vitamin C intake and the risk of gout in men: a prospective study","volume":"169","author":"Choi","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0205","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/art.21105","article-title":"The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial","volume":"52","author":"Huang","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0210","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/art.37925","article-title":"Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial","volume":"65","author":"Stamp","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0215","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/157339711795305013","article-title":"Genetic and environmental risk factors in hyperuricaemia and common gout","volume":"7","author":"Merriman","year":"2011","journal-title":"Curr Rheumatol Rev"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0220","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/bmj.295.6596.457","article-title":"Migration and gout: the Tokelau Island migrant study","volume":"295","author":"Prior","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0225","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11926-010-0088-z","article-title":"Such sweet sorrow: fructose and the incidence of gout","volume":"12","author":"Pillinger","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0230","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/ajcn\/86.4.899","article-title":"Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease","volume":"86","author":"Johnson","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0235","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diab.33.6.596","article-title":"Marked improvement in carbohydrate and lipid metabolism in diabetic Australian aborigines after temporary reversion to traditional lifestyle","volume":"33","author":"O\u2019Dea","year":"1984","journal-title":"Diabetes"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0240","doi-asserted-by":"crossref","first-page":"e39321","DOI":"10.1371\/journal.pone.0039321","article-title":"Serum uric acid and adiposity: deciphering causality using a bidirectional Mendelian randomization approach","volume":"7","author":"Lyngdoh","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0245","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1136\/annrheumdis-2012-202732","article-title":"Population-specific influence of SLC2A9 genotype on the acute hyperuricaemic response to a fructose load","volume":"72","author":"Dalbeth","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0250","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/annrheumdis-2013-203767","article-title":"Population-specific effects of SLC17A1 genotype on serum urate concentrations and renal excretion of uric acid during a fructose load","volume":"73","author":"Dalbeth","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0255","doi-asserted-by":"crossref","first-page":"R34","DOI":"10.1186\/ar4463","article-title":"Influence of the ABCG2 gout risk 141K allele on urate metabolism during a fructose challenge","volume":"16","author":"Dalbeth","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0260","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0265","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/BOR.0000000000000031","article-title":"Safety profile of anti-gout agents: an update","volume":"26","author":"Stamp","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0270","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/qjmed\/hcr242","article-title":"Recent advances in management of gout","volume":"105","author":"Suresh","year":"2012","journal-title":"QJM"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0275","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s11926-013-0398-z","article-title":"Anti-interleukin-1 therapy in the management of gout","volume":"16","author":"Schlesinger","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0280","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/RHU.0b013e3181896921","article-title":"Gout: an evidence-based review","volume":"14","author":"Chen","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0285","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0002-9343(84)90743-5","article-title":"Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency","volume":"76","author":"Hande","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0290","first-page":"1646","article-title":"Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout","volume":"33","author":"Dalbeth","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0295","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/art.34488","article-title":"Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol","volume":"64","author":"Stamp","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0300","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1073\/pnas.1207934109","article-title":"Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire","volume":"109","author":"Ostrov","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0305","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11147","article-title":"Immune self-reactivity triggered by drug-modified HLA-peptide repertoire","volume":"486","author":"Illing","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0310","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0315","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11926-010-0154-6","article-title":"Quality of care in patients with gout: why is management suboptimal and what can be done about it","volume":"13","author":"Edwards","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0320","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrrheum.2009.236","article-title":"Update on gout: new therapeutic strategies and options","volume":"6","author":"Terkeltaub","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0325","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrrheum.2014.32","article-title":"Optimizing current treatment of gout","volume":"10","author":"Rees","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0330","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/rheumatology\/kes211","article-title":"Gout and its comorbidities: implications for therapy","volume":"52","author":"Stamp","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0335","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.amjopharm.2011.07.004","article-title":"Management of gout in the older adult","volume":"9","author":"Fravel","year":"2011","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0340","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3899\/jrheum.121301","article-title":"Efficacy and tolerability of probenecid as urate-lowering therapy in gout; clinical experience in high-prevalence population","volume":"40","author":"Pui","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0345","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrd3349","article-title":"Pegloticase","volume":"10","author":"Schlesinger","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0350","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/ar2659","article-title":"Adherence with urate-lowering therapies for the treatment of gout","volume":"11","author":"Harrold","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0355","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jbspin.2011.05.010","article-title":"Treatment adherence in patients with gout","volume":"78","author":"Reach","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0360","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/ard.2007.076182","article-title":"Uric acid lowering therapy: prescribing patterns in a large cohort of older adults","volume":"67","author":"Solomon","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0365","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1742395310378761","article-title":"Patients and providers view gout differently: a qualitative study","volume":"6","author":"Harrold","year":"2010","journal-title":"Chronic Illn"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0370","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/annrheumdis-2011-200801","article-title":"Patient and provider barriers to effective management of gout in general practice: a qualitative study","volume":"71","author":"Spencer","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0375","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/acr.20570","article-title":"Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability","volume":"63","author":"Dalbeth","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0380","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10067-013-2168-8","article-title":"A qualitative and quantitative analysis of the characteristics of gout patient education resources","volume":"32","author":"Robinson","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0385","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/ket487","article-title":"Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia","author":"Fleischmann","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0390","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.rdc.2014.01.013","article-title":"Emerging therapies for gout","volume":"40","author":"Edwards","year":"2014","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0395","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jama.300.8.924","article-title":"Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial","volume":"300","author":"Feig","year":"2008","journal-title":"JAMA"},{"issue":"Suppl. 5","key":"10.1016\/j.maturitas.2014.05.001_bib0400","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.3949\/ccjm.75.Suppl_5.S13","article-title":"The role of hyperuricemia and gout in kidney and cardiovascular disease","volume":"75","author":"Edwards","year":"2008","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0405","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/ki.2013.353","article-title":"Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function","volume":"85","author":"Hughes","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0410","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/rheumatology\/kes253","article-title":"Hospital admissions associated with gout and their co-morbidities in New Zealand and England 1999\u20132009","volume":"52","author":"Robinson","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0415","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/art.20102","article-title":"Quality of care indicators for gout management","volume":"50","author":"Mikuls","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0420","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/rheumatology\/ken066","article-title":"Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels \u2013 the Third National Health and Nutrition Examination Survey","volume":"47","author":"Choi","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0425","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/rheumatology\/ker384","article-title":"Prevalence and clinical factors associated with gout in patients with diabetes and prediabetes","volume":"51","author":"Liu","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0430","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/qjmed\/hct083","article-title":"Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortality","volume":"106","author":"Stack","year":"2013","journal-title":"QJM"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0435","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1136\/bmj.f4262","article-title":"Association of plasma uric acid with ischaemic heart disease and blood pressure: Mendelian randomisation analysis of two large cohorts","volume":"347","author":"Palmer","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.maturitas.2014.05.001_bib0440","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/ki.2011.414","article-title":"Genotype-based changes in serum uric acid affect blood pressure","volume":"81","author":"Parsa","year":"2012","journal-title":"Kidney Int"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512214001534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512214001534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:59:38Z","timestamp":1759913978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512214001534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0378512214001534"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2014.05.001","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gout: Joints and beyond, epidemiology, clinical features, treatment and co-morbidities","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2014.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}